Aarti Industries Ltd · NSE:AARTIIND
Aarti Industries — Q2 FY27 Earnings Presentation
22 slides from Aarti Industries's earnings presentation, Nov 1, 2026
Slide 1: Exchange filing cover letter for Results Presentation
November 1, 2026 To, To, Listing/Compliance Department Listing/Compliance Department BSE LTD. National Stock Exchange of Phiroze Jeejeebhoy Towers, India Limited Dalal Street, “Exchange Plaza”, Plot No. C/1, Mumbai – 400 001. G Block Bandra-Kurla Complex, Bandra (E), Mumbai – 400 051. BSE CODE : 524
Slide 2: Q2 & H1 FY27 Performance Update
Q2 & H1 FY27 Performance Update 1st Nov 2026
Slide 3: Disclaimer
Disclaimer AARTI INDUSTRIES LIMITED may, from time to time, make written and oral forward-looking statements, in addition to statements contained in the company's filings with BSE Limited [BSE] and National Stock Exchange of India Limited [NSE], and our reports to shareholders. The company does not
Slide 4: Agenda
Agenda 01 Company Overview 02 Q2 & H1 FY27 Highlights 03 Future Outlook and Roadmap 3
Slide 5: Agenda
Agenda 01 Company Overview 02 Q2 & H1 FY27 Highlights 03 Future Outlook and Roadmap 4
Slide 6: Aarti Industries at a Glance
Aarti Industries at a Glance • Established by first generation technocrats in 1984 100+ 1100+ • Specialised in Benzene and Toluene based derivatives Products Domestic & Global Customers • Integrated operations and high-cost optimisation 60 16 Exporting Manufacturing Plants • Key value chains include
Slide 7: Agenda
Agenda 01 Company Overview 02 Q2 & H1 FY27 Highlights 03 Future Outlook and Roadmap 6
Slide 8: Business Highlights Q2 FY27
Business Highlights Q2 FY27 Sustainability Partnerships Volumes Growth Cost Savings Digital & AI • AIL was awarded the • Existing Long-Term • Fuel Additives • Generating value by • Building inhouse most prestigious contracts Capacity expansion implementing various capability of Digital and Sword of
Slide 9: Unlocking high-value manufacturing opportunities at Zone IV
Unlocking high-value manufacturing opportunities at Zone IV Commissioning of Phase I of Zone IV Strengthening downstream integration, application diversification and flexible manufacturing capabilities Key Highlights Strategic Benefits Next Milestone • Phase I commissioned: • Portfolio enhancement:
Slide 10: Long-term strategic manufacturing partnership
Long-term strategic manufacturing partnership Aarti Industries Enters into a 10+ Year Strategic Manufacturing & Supply Agreement Long-term partnership with a global speciality chemical company, creating sustained revenue visibility and future growth opportunities Key Deal Highlights: • Dedicated man
Slide 11: Q2 & H1 FY27 Highlights (Consolidated)
Q2 & H1 FY27 Highlights (Consolidated) ₹ in Cr YoY: 73%▲ QoQ: 48%▲ YoY: 60%▲ QoQ: 9%▲ Revenue increased due to YoY: 44%▲ QoQ: 9%▲ Overall volume growth coupled with passing-on of elevated input prices to customers. Volume Growth Energy Non-Energy YoY: 57%▲ YoY: 19%▲ QoQ: 51%▲ QoQ: 7%▲ Revenue EBITDA
Slide 12: Capacity utilization for major product groups
> 85% Capacity utilization for major product groups 65 - 85% < 65% Product Groups Capacity (in KTPA) FY25 FY26 Q1 FY27 Q2 FY27 NCB 108 DCB 120 Hydrogenation 60 PDA 12 NT 45 Ethylation 25 - 30 Methylation (Fuel additives) 360 (from July 2026) Fuel Additives DCB Debottlenecking NT & Ethylation PDA Out
Slide 13: Revenue by End Use
Revenue by End Use Agrochemicals & Fertilizers (12%) Demand remained steady; however weak monsoon might have impact in H2 Dyes, Pigments & Printing Inks (12%) Dyes, Pigment & Printing Inks segment delivered steady growth mostly driven by robust domestic demand Energy Application (50%) Strong global
Slide 14: Application wise market updates & business highlights (1/2)
Application wise market updates & business highlights (1/2) Domestic Exports End Use Agrochemical & Fertilizers Energy & Additives Chloro Anilines, Di Chloro Phenols, Ethylated & Key Products MMA, CaCl2 Fluorinated products Revenue Share 12% 50% Domestic / Exports 60% 40% 16% 84% • Stronger demand i
Slide 15: Application wise market updates & business highlights (2/2)
Application wise market updates & business highlights (2/2) Domestic Exports End Use Dyes, Pigments & Printing Inks Pharmaceuticals Polymer and additives PNCB, MDCB & Fluorinated Key Products NCBs, DCBH, PNT PDCB, MPDA, ONA compounds Revenue Share 12% 13% 10% Domestic/Exports 82% 18% 88% 12% 63% 37%
Slide 16: Joint Ventures
Joint Ventures DCA downstream JV with Superform Chemical Recycling of plastics • Project under commissioning trials; Commercial volumes • Critical equipments delivered; on ground execution to begin soon. underway • Tailwinds in one of the end applications being witnessed; • Engagement with potential
Slide 17: Agenda
Agenda 01 Company Overview 02 Q2 & H1 FY27 Highlights 03 Future Outlook and Roadmap 16
Slide 18: Key EBITDA Growth Drivers in 3-year plan (FY25 - FY28)
Key EBITDA Growth Drivers in 3-year plan (FY25 - FY28) Cost Optimisation Volume and margin ramp-up CAPEX-led growth ₹ 150-200 crore ₹ 350-550 crore ₹ 300-450 crore • Switching to Back Pressure Turbine to • Acid, DCB & NCB value chain ramp-up • Pilot commissioned to fuel New Product improve Cogen Dev
Slide 19: Long term growth focus areas
Long term growth focus areas MPP and Zone 4 Commercialization • R&D and MPP will support quick development, qualification and commercialization of new advanced chemistries • Chlorotoluene commissioning and ramp up will open up new opportunities in Agro, Pharma business segments Entry into Adjacent M
Slide 20: Growth Outlook
Growth Outlook Deliver consistent volume growth over 3 yrs driven by increased capacities Operating leverages and cost optimisation initiatives to drive EBITDA growth beyond volume growth Zone IV projects to commercialise in FY27 and to ramp up over next 18-24 months Target EBITDA range of ₹1,800-2,
Slide 21: Certifications
Certifications @ en INDUSTRIES” “ on a vadis | SUSTAINABILITY oe i \A Sustainability Rating JUN 2026 9001:2015 Responsible Care” ‘ou couTMeNTTOSUSTANABIATY
Slide 22: Thank You
Thank You [email protected]